Physician

Vel Natesan, M.D.

According to 2025 Medicare claims, Vel Natesan, M.D. (NPI: 1457372310) practices internal medicine in the Salisbury, MD market, with the plurality of this provider's patient population coming from Wicomico, MD. This provider's primary affiliated billing organization is VEL NATESAN MD PA (NPI: 1417978362; TIN: 522274957) and primary practice location at 21804-5159. Natesan is affiliated with the Aledade A2557 DE MSSP Enhanced (ACO ID: A2557), participating under the MSSP model.

Natesan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,483 traditional Medicare patients, billed 7,089 HCPCS/CPT codes, and received $422,197 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 28,064 prescription claims across 1,669 beneficiaries totaling $3,857,809 in drug costs, led by Ozempic (Semaglutide). DME data shows 1,132 claims. Open Payments data shows 47 records totaling $938. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $779,665 to $422,197. In contrast, Part D prescription costs have risen steadily, from $1,903,757 to $3,857,809. For DME billing, this smaller-volume category rose steadily, from $63,194 to $78,347.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,832	15,586	$779,665
2016	2,446	12,736	$594,650
2017	2,365	12,436	$619,383
2018	1,968	6,198	$525,343
2019	2,123	8,130	$606,781
2020	1,991	6,467	$480,761
2021	2,098	7,820	$594,229
2022	1,869	6,288	$497,168
2023	1,577	5,649	$436,167
2024	1,483	7,089	$422,197

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,561	25,188	$1,903,757
2016	1,618	26,048	$2,142,784
2017	1,733	26,352	$2,249,542
2018	1,671	28,121	$2,603,817
2019	1,645	27,661	$2,570,888
2020	1,567	27,676	$2,625,392
2021	1,569	27,179	$2,903,535
2022	1,740	28,630	$3,321,354
2023	1,762	27,807	$3,851,432
2024	1,669	28,064	$3,857,809

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	590	1,941	$89,840
2016	568	1,739	$53,829
2017	552	1,770	$54,024
2018	642	1,721	$31,781
2019	658	2,042	$67,936
2020	601	1,787	$58,388
2021	570	1,640	$66,464
2022	444	1,283	$55,008
2023	446	1,277	$61,212
2024	351	1,132	$66,989

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	1,091	1,091	$129
90653	Influenza vaccine, inactivated	277	279	$81
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,261	2,579	$53
G0008	Administration of influenza virus vaccine	291	293	$32
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	1,020	1,517	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	344	18,034	$569,345
Eliquis	Apixaban	494	24,383	$463,348
Jardiance	Empagliflozin	406	24,315	$454,099
Farxiga	Dapagliflozin Propanediol	202	11,670	$208,669
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	210	9,690	$198,307

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	22	106	$30,852
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	57	$4,444
A7031	Face mask interface, replacement for full face mask, each	N	21	45	$4,366
A7030	Full face mask used with positive airway pressure device, each	N	22	48	$4,301
A7032	Cushion for use on nasal mask interface, replacement only, each	N	13	29	$3,139

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	47	$938	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vel Natesan, M.D.?

Tedicare shows public-source Medicare data for Vel Natesan, M.D. (NPI 1457372310), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vel Natesan, M.D. have ACO affiliation data?

Vel Natesan, M.D. is shown with ACO affiliation data for Aledade A2557 DE MSSP Enhanced (MSSP, ACO ID A2557).

What billing organization is linked to Vel Natesan, M.D.?

Vel Natesan, M.D. is linked to VEL NATESAN MD PA (billing NPI 1417978362) in the available physician profile data.

Does Vel Natesan, M.D. have Open Payments data?

Vel Natesan, M.D. has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.